Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BJCT-BIOJECT-needle less injection product -- Ignore unavailable to you. Want to Upgrade?

To: Marc Kahn who wrote (86)	11/22/1997 6:42:00 PM
From: Michael C. Woodward	Read Replies (1) \| Respond to of 534

Marc, I may go this meeting. I live in Bend and am getting mountain fever and need to go to the big city. The managers of my investment group told me that they would be attending this meeting. I have so darn much of this stock, I think that it will be beneficial for me to at least meet Jim O'Shea and get a better feel for the company. I agree with you on voting positively on the Board's proposal. This will definitely give Bioject excellent cash flow. But I will want to discuss their proposal to give Raphael L.L.C. warrants to purchase 100,000 shares of Common Stock - like at what price and why should Bioject give them the warrants. I understand that Raphael brought Bioject and Elan together. In spite of the long and less than spectacular history of this company, I am very bullish on them and think CY98 will be an excellent year.